To secure the supply of drugs in the United States, and for other purposes.
Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.
Summary
What This Bill Does
This bill, To secure the supply of drugs in the United States, and for other purposes., changes federal law or congressional policy affecting federal agencies and legislative administrators. The main policy domain is Government Operations, Healthcare, Trade.
Who Benefits and How
federal agencies and legislative administrators may benefit from new authority, funding, eligibility, regulatory clarity, or reduced risk created by the bill.
Who Bears the Burden and How
federal implementing agencies may take on implementation duties, reporting obligations, compliance costs, or oversight responsibilities.
Key Provisions
- Section S1: 1. Short title This Act may be cited as the Pharmaceutical Supply Chain Defense and Enhancement Act.
- Section id979F46FE771A4C52AE3AE9CFFDB9EAB0: 2. Listing of critical drugs Not later than 1 year after the date of enactment of this Act, the Secretary, acting through the Commissioner of Food and Drugs...
- Section id23AA183232D442E78A25EF1955273CAB: 3. Boosting domestic drug and active ingredient manufacturing capacity The Secretary, acting through the Director of the Biomedical Advanced Research and...
- Section id35e646c9393045238bfe0bc4c6444d32: 4. Supply chain transparency Each domestic manufacturer of a drug that supplies such drug to the Department of Defense, the Department of Veterans Affairs, the...
- Section ide4fdcd9762da4bd7a5a90fc489787677: 5. Oversight of foreign pharmaceutical investment Not later than 1 year after the date of the enactment of this Act, and annually thereafter, the Federal Trade...
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.
At a Glance
What This Bill Does
This bill, To secure the supply of drugs in the United States, and for other purposes., changes federal law or congressional policy affecting federal agencies and legislative administrators.
Key Policy Areas
Government Operations, Healthcare, Trade
Primary Purpose
This bill, To secure the supply of drugs in the United States, and for other purposes., changes federal law or congressional policy affecting federal agencies and legislative administrators.
Policy Domains
Whole bill
Identified Gains
- federal agencies and legislative administrators
Identified Costs
- federal implementing agencies
Sponsors
Legislative Progress
IntroducedMs. Warren (for herself and Ms. Smith) introduced the following …
Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
- "the_commission"
- → The commission identified in the operative section
- "secretary_of_defense"
- → Secretary of Defense
- "secretary_of_treasury"
- → Secretary of the Treasury
- "secretary_of_health_and_human_services"
- → Secretary of Health and Human Services
Key Definitions
Terms defined in this bill
a raw material, intermediate, or a drug substance that is used in the production of a drug substance and that is incorporated as a significant structural fragment into the structure of the drug substance
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology